Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 22, 2007, Pages 9451-9456

  Mwangi, Michael M ^a,b   Shang, Wei Wu ^b,c   Zhou, Yanjiao ^b,c   Sieradzki, Krzysztof ^b   De Lencastre, Herminia ^b,d   Richardson, Paul ^e   Bruce, David ^e   Rubin, Edward ^e   Myers, Eugene ^f   Siggia, Eric D ^a,b   Tomasz, Alexander ^b  

^a Cornell University   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^e DOE JOINT GENOME INSTITUTE   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DAPTOMYCIN; OXACILLIN; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BACTERIUM ISOLATE; DRUG SENSITIVITY; GENE MUTATION; IN VIVO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; OPERON; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STAPHYLOCOCCUS AUREUS; DISEASE TRANSMISSION; DRUG EFFECT; EVOLUTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; STAPHYLOCOCCUS INFECTION;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAM RESISTANCE; DRUG RESISTANCE, MULTIPLE; EVOLUTION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, BACTERIAL; GENOME, BACTERIAL; HUMANS; MUTATION; PHENOTYPE; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 34547226145     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0609839104     Document Type: Article

References (49)

1. Appelbaum PC (2006) Clin Microbiol Infect 12(Suppl 1):16-23.
2. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997) J Antimicrob Chemother 40:135-136.
3. Sieradzki K, Roberts RB, Haber SW, Tomasz A (1999) N Engl J Med 340:517-523.
4. Charles PG, Ward PB, Johnson PD, Howden BP, Grayson ML (2004) Clin Infect Dis 38:448-451.
5. Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, Grabsch EA, Roberts SA, Robson J, Read K, et al. (2004) Clin Infect Dis 38:521-528.
6. Howden BP (2005) Intern Med J 35(Suppl 2):S136-S140.
7. Clinical and Laboratory Standards Institute (2006) Performance Standards for Antimicrobial Susceptibility Testing: 16th informational supplement M100-S16 (Clinical and Laboratory Standards Institute, Wayne, PA).
8. Howe RA, Monk A, Wootton M, Walsh TR, Enright MC (2004) Emerg Infect Dis 10:855-857.
9. Weigel LM, Clewell DB, Gill SR, Clark NC, McDougal LK, Flannagan SE, Kolonay JF, Shetty J, Killgore GE, Tenover FC (2003) Science 302:1569-1571.
10. Severin A, Tabei K, Tenover F, Chung M, Clarke N, Tomasz A (2004) J Biol Chem 279:3398-3407.
11. Sieradzki K, Tomasz A (2003) J Bacteriol 185:7103-7110.
12. Pfeltz RF, Wilkinson BJ (2004) Curr Drug Targets Infect Disord 4:273-294.
13. Avison MB, Bennett PM, Howe RA, Walsh TR (2002) J Antimicrob Chemother 49:255-260.
14. Ohta T, Hirakawa H, Morikawa K, Maruyama A, Inose Y, Yamashita A, Oshima K, Kuroda M, Hattori M, Hiramatsu K, et al. (2004) DNA Res 11:51-56.
15. Sieradzki K, Leski T, Dick J, Borio L, Tomasz A (2003) J Clin Microbiol 41:1687-1693.
16. McAleese F, Wu SW, Sieradzki K, Dunman P, Murphy E, Projan S, Tomasz A (2006) J Bacteriol 188:1120-1133.
17. Kuroda M, Ohta T, Uchiyama I, Baba T, Yuzawa H, Kobayashi I, Cui L, Oguchi A, Aoki K, Nagai Y, et al. (2001) Lancet 357:1225-1240.
18. O'Neill AJ, Huovinen T, Fishwick CW, Chopra I (2006) Antimicrob Agents Chemother 50:298-309.
19. Reynolds MG (2000) Genetics 156:1471-1481.
20. Zhang HZ, Hackbarth CJ, Chansky KM, Chambers HF (2001) Science 291:1962-1965.
21. Hackbarth CJ, Miick C, Chambers HF (1994) Antimicrob Agents Chemother 38:2568-2571.
22. Sieradzki K, Tomasz A (1999) J Bacteriol 181:7566-7570.
23. Kuroda M, Kuwahara-Arai K, Hiramatsu K (2000) Biochem Biophys Res Commun 269:485-490.
24. Sakoulas G, Eliopoulos GM, Moellering RC, Jr, Wennersten C, Venkataraman L, Novick RP, Gold HS (2002) Antimicrob Agents Chemother 46:1492-1502.
25. Sakoulas G, Eliopoulos GM, Fowler VG, Jr, Moellering RC, Jr, Novick RP, Lucindo N, Yeaman MR, Bayer AS (2005) Antimicrob Agents Chemother 49:2687-2692.
26. Szurmant H, Nelson K, Kim EJ, Perego M, Hoch JA (2005) J Bacteriol 187:5419-5426.
27. Dubrac S, Msadek T (2004) J Bacteriol 186:1175-1181.
28. Sieradzki K, Tomasz A (2006) Antimicrob Agents Chemother 50:527-533.
29. Schaaper RM, Dunn RL (1987) Proc Natl Acad Sci USA 84:6220-6224.
30. Moxon ER, Rainey PB, Nowak MA, Lenski RE (1994) Curr Biol 4:24-33.
31. Boyle-Vavra S, Berke SK, Lee JC, Daum RS (2000) Antimicrob Agents Chemother 44:272-277.
32. Durack DT, Beeson PB (1972) Br J Exp Pathol 53:50-53.
33. Beeson PB, Brannon ES, Warren JV (1945) J Exp Med 81:9-23.
34. Alder JD (2005) Drugs Today (Barc) 41:81-90.
35. Petersen PJ, Bradford PA, Weiss WJ, Murphy TM, Sum PE, Projan SJ (2002) Antimicrob Agents Chemother 46:2595-2601.
36. Patel JB, Jevitt LA, Hageman J, McDonald LC, Tenover FC (2006) Clin Infect Dis 42:1652-1653.
37. Cui L, Tominaga E, Neoh HM, Hiramatsu K (2006) Antimicrob Agents Chemother 50:1079-1082.
38. Friedman L, Alder JD, Silverman JA (2006) Antimicrob Agents Chemother 50:2137-2145.
39. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K (2003) Mol Microbiol 49:807-821.
40. Dunman PM, Murphy E, Haney S, Palacios D, Tucker-Kellogg G, Wu S, Brown EL, Zagursky RJ, Shlaes D, Projan SJ (2001) J Bacteriol 183:7341-7353.
41. Korem M, Gov Y, Kiran MD, Balaban N (2005) Infect Immun 73:6220-6228.
42. Liang X, Zheng L, Landwehr C, Lunsford D, Holmes D, Ji Y (2005) J Bacteriol 187:5486-5492.
43. Maughan H, Galeano B, Nicholson WL (2004) J Bacteriol 186:2481-2486.
44. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG (2000) J Clin Microbiol 38:1008-1015.
45. Centers for Disease Control and Prevention (1997) Morbid Mortal Wkly Rep 46:813-815.
46. Yin S, Daum RS, Boyle-Vavra S (2006) Antimicrob Agents Chemother 50:336-343.
47. Gardete S, Wu SW, Gill S, Tomasz A (2006) Antimicrob Agents Chemother 50:3424-3434.
48. Service RF (2006) Science 311:1544-1546.
49. Rambaut A, Posada D, Crandall KA, Holmes EC (2004) Nat Rev Genet 5:52-61.